(Reuters) – A slimmed-down Rite Aid Corp could lose much of its bargaining heft with insurers and makers of branded drugs at a time when it is trying to turn around its flagging pharmacy business, analysts said.
Walgreens deal offers no lasting relief to Rite Aid
Jun 30, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital